Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Larkin J, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Espinosa E, Garbe C, Sileni VC, Gogas H, Miller WH Jr, Mandalà M, Hospers GA, Arance A, Queirolo P, Hauschild A, Brown MP, Mitchell L, Veronese L, Blank CU. Larkin J, et al. Among authors: espinosa e. Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27. Lancet Oncol. 2014. PMID: 24582505 Clinical Trial.
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
Feliu J, González Barón M, García Girón C, Espinosa E, Vicent JM, Gómez Navarro J, Berrocal A, Ordóñez A, Vilches Y, de Castro J, Díaz J. Feliu J, et al. Among authors: espinosa e. Am J Clin Oncol. 1996 Dec;19(6):577-80. doi: 10.1097/00000421-199612000-00009. Am J Clin Oncol. 1996. PMID: 8931675 Clinical Trial.
UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
González Barón M, Feliu J, Garcia Girón C, Espinosa J, Martinez B, Blanco E, Crespo MC, Ordóñez A, Espinosa E, de Castro J, Juárez F, Colmenarejo A. González Barón M, et al. Among authors: espinosa j, espinosa e. Oncology. 1997;54 Suppl 1:24-9. doi: 10.1159/000227742. Oncology. 1997. PMID: 8978581 Clinical Trial.
Small molecules and targeted therapies in distant metastatic disease.
Hersey P, Bastholt L, Chiarion-Sileni V, Cinat G, Dummer R, Eggermont AM, Espinosa E, Hauschild A, Quirt I, Robert C, Schadendorf D. Hersey P, et al. Among authors: espinosa e. Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi35-40. doi: 10.1093/annonc/mdp254. Ann Oncol. 2009. PMID: 19617296 Free PMC article. Review.
Immunotherapy of distant metastatic disease.
Schadendorf D, Algarra SM, Bastholt L, Cinat G, Dreno B, Eggermont AM, Espinosa E, Guo J, Hauschild A, Petrella T, Schachter J, Hersey P. Schadendorf D, et al. Among authors: espinosa e. Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi41-50. doi: 10.1093/annonc/mdp253. Ann Oncol. 2009. PMID: 19617297 Free PMC article. Review.
Advances in cutaneous melanoma.
Espinosa E, Berrocal A, López Martín JA, González Cao M, Cerezuela P, Mayordomo JI, Martín Algarra S; Grupo Español de Melanoma (GEM). Espinosa E, et al. Clin Transl Oncol. 2012 May;14(5):325-32. doi: 10.1007/s12094-012-0804-4. Clin Transl Oncol. 2012. PMID: 22551537 Review.
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Martín-Algarra S, Fernández-Figueras MT, López-Martín JA, Santos-Briz A, Arance A, Lozano MD, Berrocal A, Ríos-Martín JJ, Espinosa E, Rodríguez-Peralto JL; Spanish Society of Pathology; Spanish Society of Medical Oncology. Martín-Algarra S, et al. Among authors: espinosa e. Clin Transl Oncol. 2014 Apr;16(4):362-73. doi: 10.1007/s12094-013-1090-5. Epub 2013 Oct 16. Clin Transl Oncol. 2014. PMID: 24129426
Who benefits most from adjuvant interferon treatment for melanoma?
Gogas H, Abali H, Ascierto PA, Demidov L, Pehamberger H, Robert C, Schachter J, Eggermont AM, Hauschild A, Espinosa E. Gogas H, et al. Among authors: espinosa e. Am J Ther. 2015 Jan-Feb;22(1):54-60. doi: 10.1097/MJT.0b013e31829e883d. Am J Ther. 2015. PMID: 24176884 Review.
Side effects and toxicities of targeted therapies in stage IV melanoma.
Ascierto PA, Bastholt L, Hersey P, Cinat G, Eggermont AM, Hauschild A, Espinosa E, Robert C. Ascierto PA, et al. Among authors: espinosa e. Am J Ther. 2015 Jan-Feb;22(1):44-53. doi: 10.1097/MJT.0b013e3182a39858. Am J Ther. 2015. PMID: 24185314 Review.
Treatment algorithms in stage IV melanoma.
Espinosa E, Grob JJ, Dummer R, Rutkowski P, Robert C, Gogas H, Kefford R, Eggermont AM, Martin Algarra S, Hauschild A, Schadendorf D. Espinosa E, et al. Am J Ther. 2015 Jan-Feb;22(1):61-7. doi: 10.1097/MJT.0b013e31829e885c. Am J Ther. 2015. PMID: 24413374 Free article. Review.
574 results